First Affiliated Hospital Of Chongqing Medical University
Clinical trials sponsored by First Affiliated Hospital Of Chongqing Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a common acid blocker save transplanted kidneys? Results expected Oct 2026 (estimated)
- Ultrasound-Guided fluid therapy may cut lung risks in elderly cancer surgery Results expected Dec 2026 (estimated)
- New antibody treatment could tame rare brain disease Flare-Ups Results expected Dec 2026 (estimated)
- New hope for teens with tough depression: study tests Next-Step treatments Results expected Dec 2026 (estimated)
- Can a sugary drink before Weight-Loss surgery speed up gut recovery? Results expected Jan 2027 (estimated)
-
Could a smart computer tool help prevent kidney failure in people with diabetes?
Disease control Not yet recruitingThis study tests a smart computer system that helps primary care doctors screen for and manage diabetic kidney disease in adults with type 2 diabetes. The tool automatically calculates kidney function, reminds doctors to order urine tests, and gives personalized treatment advice.…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Ultrasound-Guided fluid therapy may cut lung risks in elderly cancer surgery
Disease control Not yet recruitingThis trial investigates whether using a special ultrasound score (VExUS) to guide fluid delivery during surgery can lower the chance of lung complications in patients aged 65–80 undergoing minimally invasive esophageal cancer removal. Participants are randomly assigned to receive…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Experimental drug talquetamab takes aim at stubborn myasthenia gravis
Disease control Not yet recruitingThis very early study will test the drug talquetamab in just 2 people with refractory generalized myasthenia gravis, a chronic autoimmune disease that causes muscle weakness. The drug is designed to help the immune system attack the cells that produce harmful antibodies. The goal…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New cocktail aims to outsmart Drug-Resistant liver cancer
Disease control Not yet recruitingThis study tests a combination of three drugs—ivarmacitinib, camrelizumab, and apatinib—in 65 people with advanced liver cancer that has stopped responding to initial immunotherapy. The goal is to see if this triple therapy can shrink tumors or slow disease progression. Participa…
Phase 2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New antibody treatment could tame rare brain disease Flare-Ups
Disease control Not yet recruitingThis study tests whether monoclonal antibodies can safely and effectively treat acute attacks of neuromyelitis optica spectrum disorder (NMOSD), a rare disease that causes inflammation in the eyes and spinal cord. Researchers will enroll 40 adults experiencing a recent flare-up a…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 26, 2026 19:21 UTC
-
Can a sugary drink before Weight-Loss surgery speed up gut recovery?
Symptom relief Not yet recruitingResearchers are testing whether a carbohydrate-rich clear drink given two hours before bariatric surgery helps patients with metabolic syndrome recover normal gastrointestinal function faster. About 208 adults scheduled for gastric bypass or sleeve gastrectomy will be randomly as…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could quick brain zaps lift teen depression? small study aims to find out
Symptom relief Not yet recruitingThis pilot study will test a type of brain stimulation called accelerated intermittent theta-burst stimulation (a-iTBS) in 45 adolescents aged 12-18 with major depressive disorder. Participants will get either real or sham stimulation, guided by MRI scans. The goal is to see if i…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Could a gentle brain current lift teen depression without drugs?
Symptom relief Not yet recruitingThis pilot study tests whether a non-invasive device that sends a mild alternating current to the brain (tACS) can safely ease depression symptoms in 30 teenagers who have never taken antidepressants. Participants will receive daily sessions over several weeks, and researchers wi…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Personalizing kidney treatment: can biomarkers predict who benefits from finerenone?
Knowledge-focused Not yet recruitingThis study follows 425 adults with type 2 diabetes and chronic kidney disease who are taking finerenone, a standard medication. Researchers collect blood and urine samples over four months to look for biomarkers that predict whether the drug helps reduce kidney damage. The goal i…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Scientists hunt for clues in gut and urine to understand urinary blockages
Knowledge-focused Not yet recruitingThis observational study will compare the gut and urine bacteria, as well as metabolic profiles, of 120 people with ureteral stricture (a narrowing of the tube from kidney to bladder) against healthy volunteers. Researchers aim to find differences that could explain why the condi…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC